Skip to content

Treatment of genital warts with cryotherapy and garlic extract

A clinical study of efficacy of garlic extract versus cryotherapy in the treatment of genital wart

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20151123025202N20
Enrollment
100
Registered
2022-02-28
Start date
2022-03-11
Completion date
Unknown
Last updated
2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Genital Wart. Anogenital (venereal) warts

Interventions

Intervention 1: Intervention group: Will be treated with garlic extract. In order to provide garlic extract, first, pour 20 cloves of garlic in a mixer until completely chopped, then add methanol and

Sponsors

Hamedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Genital warts (vulva, vagina and pubis) No history of treatment in the last 6 months

Exclusion criteria

Exclusion criteria: Having underlying diseases (atopy, diabetes, hypertension, ischemic heart disease, history of heart attack or stroke, chronic kidney disease) Taking immunosuppressive drugs Congenital or acquired immunodeficiency

Design outcomes

Primary

MeasureTime frame
Lesion recovery rate. Timepoint: Before treatment and every 15 days after treatment for 8 weeks. Method of measurement: Clinical examination and observation, Scoring based on Ordinal scale: poor moderate good.

Secondary

MeasureTime frame
Duration of treatment. Timepoint: Once every 15 days for 8 weeks. Method of measurement: Clinical examination.;Side effects of treatment. Timepoint: Once every 15 days for 8 weeks. Method of measurement: Clinical examination and questioning of the patient.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSamar Moghadami

Hamedan University of Medical Sciences

a.moradi@umsha.ac.ir+98 81 1827 7459

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026